TP53 and Alzheimer disease: Therefore, the role of p53 in AD pathology may need to be revisited, as dysregulation of p53 activity throughout the disease continuum may underlie the oxidative stress hypothesis, which is known to be an early determinant of the pathogenesis of AD [5].